Leerink Partnrs Has Positive Estimate for AbbVie Q2 Earnings
AbbVie Inc. (NYSE:ABBV – Free Report) – Research analysts at Leerink Partnrs lifted their Q2 2025 earnings estimates for shares of AbbVie in a research report issued to clients and investors on Monday, April 28th. Leerink Partnrs analyst D. Risinger now expects that the company will earn $3.24 per share for the quarter, up from […]
AbbVie Inc. (NYSE:ABBV – Free Report) – Research analysts at Leerink Partnrs lifted their Q2 2025 earnings estimates for shares of AbbVie in a research report issued to clients and investors on Monday, April 28th. Leerink Partnrs analyst D. Risinger now expects that the company will earn $3.24 per share for the quarter, up from […]
